Role of arterial blood glucose and interstitial fluid glucose difference in evaluating microcirculation and clinical prognosis of patients with septic shock: a prospective observational study.
Arterial blood glucose and interstitial fluid glucose difference
Microcirculation
Peripheral circulation
Sepsis
Septic shock
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
03 Sep 2024
03 Sep 2024
Historique:
received:
24
11
2023
accepted:
20
08
2024
medline:
4
9
2024
pubmed:
4
9
2024
entrez:
3
9
2024
Statut:
epublish
Résumé
Microcirculation abnormality in septic shock is closely associated with organ dysfunction and mortality rate. It was hypothesized that the arterial blood glucose and interstitial fluid (ISF) glucose difference (G The present observational study enrolled patients with septic shock admitted to and treated in the intensive care unit (ICU) of a tertiary teaching hospital. The parameters reflecting organ and tissue perfusion, including lactic acid (Lac), skin mottling score, capillary refill time (CRT), venous-to-arterial carbon dioxide difference (Pv-aCO A total of 43 septic shock patients were included, with median sequential organ failure assessment (SOFA) scores of 10.5 (6-16), and median Acute Physiology and Chronic Health Evaluation (APACHAE) II scores of 25.7 (9-40), of whom 18 died during ICU stay. The G G
Sections du résumé
BACKGROUND
BACKGROUND
Microcirculation abnormality in septic shock is closely associated with organ dysfunction and mortality rate. It was hypothesized that the arterial blood glucose and interstitial fluid (ISF) glucose difference (G
METHODS
METHODS
The present observational study enrolled patients with septic shock admitted to and treated in the intensive care unit (ICU) of a tertiary teaching hospital. The parameters reflecting organ and tissue perfusion, including lactic acid (Lac), skin mottling score, capillary refill time (CRT), venous-to-arterial carbon dioxide difference (Pv-aCO
RESULTS
RESULTS
A total of 43 septic shock patients were included, with median sequential organ failure assessment (SOFA) scores of 10.5 (6-16), and median Acute Physiology and Chronic Health Evaluation (APACHAE) II scores of 25.7 (9-40), of whom 18 died during ICU stay. The G
CONCLUSION
CONCLUSIONS
G
Identifiants
pubmed: 39227759
doi: 10.1186/s12879-024-09768-1
pii: 10.1186/s12879-024-09768-1
doi:
Substances chimiques
Blood Glucose
0
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
910Subventions
Organisme : the Science and Technology Plan Special Fund (Key R&D Plan Social Development) Project of Jiangsu Province
ID : BE2023706
Informations de copyright
© 2024. The Author(s).
Références
Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47:1181–247.
doi: 10.1007/s00134-021-06506-y
pubmed: 34599691
pmcid: 8486643
Bauer M, Gerlach H, Vogelmann T, Preissing F, Stiefel J, Adam D. Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019- results from a systematic review and meta-analysis. Crit Care (London England). 2020;24:239.
doi: 10.1186/s13054-020-02950-2
Markwart R, Saito H, Harder T, Tomczyk S, Cassini A, Fleischmann-Struzek C, et al. Epidemiology and burden of sepsis acquired in hospitals and intensive care units: a systematic review and meta-analysis. Intensive Care Med. 2020;46:1536–51.
doi: 10.1007/s00134-020-06106-2
pubmed: 32591853
pmcid: 7381455
Lelubre C, Vincent JL. Mechanisms and treatment of organ failure in sepsis. Nat Rev Nephrol. 2018;14:417–27.
doi: 10.1038/s41581-018-0005-7
pubmed: 29691495
Furst B, Bughrara N, Musuku SR. Macrocirculation and Microcirculation in Septic Shock. Anesth Analg. 2021;133:e37–8.
doi: 10.1213/ANE.0000000000005630
pubmed: 34403395
Levy B. Lactate and shock state: the metabolic view. Curr Opin Crit Care. 2006;12:315–21.
doi: 10.1097/01.ccx.0000235208.77450.15
pubmed: 16810041
Ait-Oufella H, Lemoinne S, Boelle PY, Galbois A, Baudel JL, Lemant J, et al. Mottling score predicts survival in septic shock. Intensive Care Med. 2011;37:801–7.
doi: 10.1007/s00134-011-2163-y
pubmed: 21373821
Coudroy R, Jamet A, Frat JP, Veinstein A, Chatellier D, Goudet V, et al. Incidence and impact of skin mottling over the knee and its duration on outcome in critically ill patients. Intensive Care Med. 2015;41:452–9.
doi: 10.1007/s00134-014-3600-5
pubmed: 25516087
Raia L, Gabarre P, Bonny V, Urbina T, Missri L, Boelle PY, et al. Kinetics of capillary refill time after fluid challenge. Ann Intensiv Care. 2022;12:74.
doi: 10.1186/s13613-022-01049-x
Ospina-Tascón GA, Bautista-Rincón DF, Umaña M, Tafur JD, Gutiérrez A, García AF, et al. Persistently high venous-to-arterial carbon dioxide differences during early resuscitation are associated with poor outcomes in septic shock. Crit Care (London England). 2013;17:R294.
doi: 10.1186/cc13160
Ospina-Tascón GA, Umaña M, Bermúdez WF, Bautista-Rincón DF, Valencia JD, Madriñán HJ, et al. Can venous-to-arterial carbon dioxide differences reflect microcirculatory alterations in patients with septic shock? Intensive Care Med. 2016;42:211–21.
doi: 10.1007/s00134-015-4133-2
pubmed: 26578172
Vallée F, Mateo J, Dubreuil G, Poussant T, Tachon G, Ouanounou I, et al. Cutaneous ear lobe Pco₂ at 37°C to evaluate microperfusion in patients with septic shock. Chest. 2010;138:1062–70.
doi: 10.1378/chest.09-2690
pubmed: 20472858
Pickup J. Sensitive glucose sensing in diabetes. Lancet (London England). 2000;355:426–7.
doi: 10.1016/S0140-6736(00)82006-1
pubmed: 10841120
Cobelli C, Schiavon M, Dalla Man C, Basu A, Basu R. Interstitial fluid glucose is not just a shifted-in-time but a distorted Mirror of blood glucose: insight from an in Silico Study. Diabetes Technol Ther. 2016;18:505–11.
doi: 10.1089/dia.2016.0112
pubmed: 27253751
pmcid: 4991590
Gerritsen M, Jansen JA, Lutterman JA. Performance of subcutaneously implanted glucose sensors for continuous monitoring. Neth J Med. 1999;54:167–79.
doi: 10.1016/S0300-2977(99)00006-6
pubmed: 10218387
D’Orazio P, Burnett RW, Fogh-Andersen N, Jacobs E, Kuwa K, Külpmann WR, et al. Approved IFCC recommendation on reporting results for blood glucose (abbreviated). Clin Chem. 2005;51:1573–6.
doi: 10.1373/clinchem.2005.051979
pubmed: 16120945
Ince C. Hemodynamic coherence and the rationale for monitoring the microcirculation. Crit Care (London England). 2015;19 Suppl 3:S8.
doi: 10.1186/cc14726
Siddall E, Khatri M, Radhakrishnan J. Capillary leak syndrome: etiologies, pathophysiology, and management. Kidney Int. 2017;92:37–46.
doi: 10.1016/j.kint.2016.11.029
pubmed: 28318633
Chinkes D, deMelo E, Zhang XJ, Traber DL, Wolfe RR. Increased plasma glucose clearance in sepsis is due to increased exchange between plasma and interstitial fluid. Shock (Augusta Ga). 1995;4:356–60.
doi: 10.1097/00024382-199511000-00008
pubmed: 8595523
Bayir H, Kagan VE. Bench-to-bedside review: mitochondrial injury, oxidative stress and apoptosis–there is nothing more practical than a good theory. Critical care (London, England). 2008; 12: 206.
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus definitions for Sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801–10.
doi: 10.1001/jama.2016.0287
pubmed: 26903338
pmcid: 4968574
Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, et al. The SOFA (Sepsis-related Organ failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707–10.
doi: 10.1007/BF01709751
pubmed: 8844239
Goldhill DR, Sumner A. APACHE II, data accuracy and outcome prediction. Anaesthesia. 1998;53:937–43.
doi: 10.1046/j.1365-2044.1998.00534.x
pubmed: 9893535
Bourcier S, Pichereau C, Boelle PY, Nemlaghi S, Dubée V, Lejour G, et al. Toe-to-room temperature gradient correlates with tissue perfusion and predicts outcome in selected critically ill patients with severe infections. Ann Intensiv Care. 2016;6:63.
doi: 10.1186/s13613-016-0164-2
Luo JC, Zhang JD, Zhao QY, Wang H, Tu GW, Luo MH, Infrared thermography-based body-surface thermal inhomogeneity monitoring to assess the severity of hypoperfusion in critically ill patients, et al. Shock (Augusta Ga). 2022;58:366–73.
pubmed: 36155398
Fogh-Andersen N, Altura BM, Altura BT, Siggaard-Andersen O. Composition of interstitial fluid. Clin Chem. 1995;41:1522–5.
doi: 10.1093/clinchem/41.10.1522
pubmed: 7586528
Miller PR, Taylor RM, Tran BQ, Boyd G, Glaros T, Chavez VH, et al. Extraction and biomolecular analysis of dermal interstitial fluid collected with hollow microneedles. Commun Biology. 2018;1:173.
doi: 10.1038/s42003-018-0170-z
Tran BQ, Miller PR, Taylor RM, Boyd G, Mach PM, Rosenzweig CN, et al. Proteomic characterization of dermal interstitial fluid extracted using a Novel Microneedle-assisted technique. J Proteome Res. 2018;17:479–85.
doi: 10.1021/acs.jproteome.7b00642
pubmed: 29172549
Samant PP, Niedzwiecki MM, Raviele N, Tran V, Mena-Lapaix J, Walker DI et al. Sampling interstitial fluid from human skin using a microneedle patch. Sci Transl Med. 2020; 12.
Renard E. Implantable continuous glucose sensors. Curr Diabetes Rev. 2008;4:169–74.
doi: 10.2174/157339908785294406
pubmed: 18690897
Battelino T, Alexander CM, Amiel SA, Arreaza-Rubin G, Beck RW, Bergenstal RM, et al. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement. Lancet Diabetes Endocrinol. 2023;11:42–57.
doi: 10.1016/S2213-8587(22)00319-9
pubmed: 36493795
Ballesteros D, Martínez Ó, Blancas Gómez-Casero R, Martín Parra C, López Matamala B, Estébanez B, et al. Continuous tissue glucose monitoring correlates with measurement of intermittent capillary glucose in patients with distributive shock. Med Intensiva. 2015;39:405–11.
doi: 10.1016/j.medin.2014.09.004
pubmed: 25499901
Gottschalk A, Welp HA, Leser L, Lanckohr C, Wempe C, Ellger B. Continuous glucose monitoring in patients undergoing extracorporeal ventricular assist therapy. PLoS ONE. 2016;11:e0148778.
doi: 10.1371/journal.pone.0148778
pubmed: 26963806
pmcid: 4786282
Bakker J. Clinical use of peripheral perfusion parameters in septic shock. Curr Opin Crit Care. 2021;27:269–73.
doi: 10.1097/MCC.0000000000000826
pubmed: 33852500
Uchimido R, Schmidt EP, Shapiro NI. The glycocalyx: a novel diagnostic and therapeutic target in sepsis. Crit Care (London England). 2019;23(1):16.
doi: 10.1186/s13054-018-2292-6